STEP4NAMs

The STEP4NAMs Podcast

Education EN ↓ 3 episodes

Human-relevant, innovation-driven and animal-free — New Approach Methodologies (NAMs) are reshaping how we develop drugs and medical devices. STEP4NAMs, a European project co-funded by Interreg North-West Europe, is at the heart of this transformation. The project focuses on the validation of NAMs to make them accessible, reliable and ready for regulatory and industrial uptake. Through sector-specific action plans, hands-on pilot studies and a dedicated training and support programme, we are paving the way for safer, faster and more ethical testing solutions. In each episode, you’ll hear direc...

Author

STEP4NAMs

Episodes

NAMs Need Skills and Guidance: Insights from a Live BioFIT Discussion 18.02.2026 30:53

In this episode of the STEP4NAMs podcast, we take you to BioFIT in Strasbourg, one of Europe’s key life science innovation events, where we hosted a live panel discussion with experts from industry, academia, and innovation networks. Building on the STEP4NAMs analysis and stakeholder interviews across North-West Europe, the discussion explores why the adoption of New Approach Methodologies (NAMs)...

Meet the Pilots 06.11.2025 32:04

In this episode of the STEP4NAMs Podcast, we explore how four pilot studies are bringing New Approach Methodologies (NAMs) into real-world application. From digital twins and organ-on-chip models to organoids and bench-top simulations, these pilots demonstrate how science can replace animal testing with human-relevant innovation. Each pilot lead explains what they’re working on, what’s being valid...

Welcome to STEP4NAMs 07.10.2025 19:11

In this opening episode, we introduce the STEP4NAMs project and its vision: accelerating the adoption of New Approach Methodologies (NAMs) across North-West Europe. Listeners will learn why NAMs matter for drug safety and medical device development, about the origin of STEP4NAMs, how the project brings together experts from six countries and what impact the project aims to achieve for SMEs, regula...